RecruitingNCT06673121
Respiratory Disease Cohort Studies of Chinese Medicine for Pulmonary Nodule
Respiratory Disease Cohort Studies of Chinese Medicine for Pulmonary Nodule （RESEARCH-PN）
Sponsor
Third Affiliated Hospital of Henan University of Traditional Chinese Medicine
Enrollment
5,000 participants
Start Date
Jan 3, 2024
Study Type
OBSERVATIONAL
Conditions
Summary
This study is a prospective multicenter cohort study that primarily evaluates the impact of traditional Chinese medicine treatment on pulmonary nodules
Eligibility
Inclusion Criteria1
- ① Patients with pulmonary nodules and recommended for follow-up by MDT; ② Voluntarily sign the informed consent form.
Exclusion Criteria1
- ①Patients with metastatic pulmonary nodules; ②Patients with benign diseases such as pulmonary lymph nodes, hamartomas, sclerosing alveolar cell tumors, or nodules with obvious benign features such as calcification; ③Patients withserious heart, lung, liver and kidney diseases.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGTraditional Chinese Medicine
Received treatment with traditional Chinese medicine
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06673121
Related Trials
European Real-World Registry for Use of the Ion Endoluminal System
NCT069237745 locations
A Combined Biomarker Model for Risk Stratification of Indeterminate Pulmonary Nodules
NCT060741334 locations
Remimazolam for Bronchoscopy in High-Risk Patients
NCT073955962 locations
The Efficacy and Safety of the Supraglottic Oxygenation Via Nasotracheal Intubation for Deep Sedation Fiberoptic Bronchoscopy
NCT073890831 location
Risks and Benefits of Radiofrequency Ablation for Chronic Venous Insufficiency (CEAP C3-C6) in Patients Aged 80 and Over
NCT072336161 location